PIM
ABBV icon

Platinum Investment Management’s AbbVie ABBV Stock Holding History

Platinum Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.57M Hold
30,102
– – 1.86% 13
2026
Q1 		$6.55M Hold
30,102
– – 1.65% 14
2025
Q4 		$6.88M Sell
30,102
-340,057
-92% -$77.5M 1.59% 12
2025
Q3 		$85.7M Buy
370,159
+4,719
+1% +$961K 5.54% 3
2025
Q2 		$67.8M Sell
365,440
-52,927
-13% -$9.84M 4.51% 10
2025
Q1 		$87.7M Buy
+418,367
New +$81.3M 5.08% 9

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Platinum Investment Management's ABBV Position: Q2 2026 in Review

Platinum Investment Management held its AbbVie (ABBV) position steady in Q2 2026 at 30,102 shares worth $7.57M. The position accounts for 1.86% of the portfolio, ranked #13.

Platinum Investment Management first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. The position peaked at $87.7M in Q1 2025. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Platinum Investment Management held 30,102 shares of AbbVie worth $7.57M as of Q2 2026.
  • Platinum Investment Management left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 1.86% of Platinum Investment Management's portfolio in Q2 2026, its #13 holding.
  • Platinum Investment Management first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • Platinum Investment Management's AbbVie position peaked at $87.7M in Q1 2025.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Platinum Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.